To provide for approval of certain drugs and biological products indicated for use in a well-defined population of patients in order to address increases in bacterial resistance to drugs and biological products, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Connecticut's 3rd congressional district. Democrat.
Last Updated: Feb 12, 2015
Length: 10 pages
Feb 12, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on February 12, 2015, in a previous session of Congress, but was not enacted.
What stakeholders are saying
Feb 12, 2015
H.R. 931 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2018). H.R. 931 — 114th Congress: HEAL Act. Retrieved from https://www.govtrack.us/congress/bills/114/hr931
“H.R. 931 — 114th Congress: HEAL Act.” www.GovTrack.us. 2015. February 22, 2018 <https://www.govtrack.us/congress/bills/114/hr931>
|title=H.R. 931 (114th)
|accessdate=February 22, 2018
|author=114th Congress (2015)
|date=February 12, 2015